J. Anne Nizze - Concepedia

Concepedia

Author

J. Anne Nizze

Saint John's Health Center

Also Known As

J A Nizze, J. A. Nizze, J. ANNE NIZZE, J. Anne Nizze

13

Publications

1.4K

Citations

11

H-Index

24

Concepts

All Affiliations

Saint John's Health Center University of California, Los Angeles

JA

About

J. Anne Nizze is an author at Saint John's Health Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	433
2	Immunology	5	5	329
3	Allergy	2	2	83
4	Clinical Immunology	1	1	132
5	Pathology	1	1	104

J. Anne Nizze

×

10

Publications

1.4K

Citations

10

H-Index

	Year	Citations
Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine Donald L. Morton, Leland J. Foshag, Dave S.�B. Hoon, Annals of Surgery	1992	404
Improved Long-term Survival After Lymphadenectomy of Melanoma Metastatic to Regional Nodes Donald L. Morton, Leslie A. Wanek, J. Anne Nizze, Annals of Surgery	1991	336
Prolonged Survival of Patients Receiving Active Immunotherapy With Canvaxin Therapeutic Polyvalent Vaccine After Complete Resection of Melanoma Metastatic to Regional Lymph Nodes Donald L. Morton, Eddy C. Hsueh, Richard Essner, Annals of Surgery	2002	147
Sequential evaluation of general immune competence in cancer patients: Correlation with clinical course Frederick R. Eilber, J. Anne Nizze, Donald L. Morton Cancer Clinical ImmunologyImmunologyImmunoeditingImmunotherapeuticsCancer Patients	1975	132
Recurrence potential of thin primary melanomas Peter L. Naruns, J. Anne Nizze, Alistair J. Cochran, Cancer Systemic MetastasesSurgical OncologyMelanoma MetastasesPathologyRecurrence Potential	1986	104
Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response. Andreas S. Barth, Dave S.�B. Hoon, Leland J. Foshag, PubMed ImmunologyImmunotherapeuticsVaccine TherapyImmunotherapyDelayed-type Hypersensitivity	1994	69
Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases Eddy C. Hsueh, Larry Nathanson, Leland J. Foshag, Cancer	1999	69
Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanomaa Donald L. Morton, Dave S.�B. Hoon, J. Anne Nizze, Annals of the New York Academy of Sciences VaccinationMetastatic MelanomaaTumor ImmunologyOncologyMelanoma	1993	59
Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: An immunologic survival model Ralph C. Jones, Mark R. Kelley, Rishab K. Gupta, Annals of Surgical Oncology VaccinationCancer ImmunosurveillanceMelanoma Cell VaccineMelanomaImmunology	1996	55
Lack of Correlation between Skin Reactivity to Dinitrochlorobenzene and Croton Oil in Patients with Cancer Jack A. Roth, Frederick R. Eilber, J. Anne Nizze, New England Journal of Medicine ImmunologyPharmacotherapyDepressed Cellular ImmunityDermatologyImmunotherapy	1975	14

Page 1